Nasopharyngeal Microbiota as an early severity biomarker in COVID-19 hospitalised patients: a retrospective cohort study in a Mediterranean area.
M. P. Ventero, O. Moreno-Perez, C. Molina-Pardines, A. Paytuvi-Gallart, V. Boix, I. Galan, P. Gonzalez-delaAleja, M. Lopez-Perez, R. Sanchez-Martinez, E. Merino, J. C. Rodriguez
This study identifies nasopharyngeal microbiota diversity and specific taxa as early biomarkers for reduced severity in hospitalized COVID-19 patients.
bioRxiv · Sep 28, 2021Microbiology